First cross-listing of Invesco QQQ outside of North America; QQQ is the second most traded US ETF 

Important Information 

• The Trust seeks to track the investment results, before fees and expenses, of the Nasdaq-100 Index^® (“Index”).
• Investors should note the equity market risk, concentration risk of investing in the US market and in companies in the technology sector, technology sector risks, passive investment risk, trading risks, trading hours different risk, foreign exchange risks, multi-counter risks, reliance on market maker risks, termination risk and general investment risk.
• The Trust may be subject to tracking error risk, which is the risk that its performance may not track that of the Index exactly.
• Payment of distributions out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor’s original investment or from any capital gains attributable to that original investment and may result in an immediate reduction in the Net Asset Value (“NAV”) per share of the Trust (“Share”).
• All Shares will receive distributions in the base currency (USD) only. In the event that a Trust Shareholder has no USD account, the Trust Shareholder may have to bear the fees and charges associated with the conversion of such distributions from USD to HKD or RMB or any other currency.
• NAV and trading price of the Shares can be volatile and could go down substantially.
• Investors should not base their investment decision on this material alone.

HONG KONG, Feb. 26, 2025 /PRNewswire/ — Invesco, a leading global asset management firm, announced today that its flagship Invesco QQQ Trust Exchange Traded Fund (Invesco QQQ ETF) has been approved for sale in Hong Kong by the Securities & Futures Commission and cross-listed on the Hong Kong Stock Exchange (HKEX), commencing trading as of market open under the symbol “3455”. Invesco QQQ, one of the best-performing large-cap growth funds^[1], is the flagship fund of Invesco’s US$762 billion ETF business, the fourth largest ETF provider globally^[2]. 

With approximately US$318.9 billion in assets under management (AUM)^[3], Invesco QQQ is the world’s fifth largest ETF and second most traded ETF in the US^[4].  The launch marks the first cross-listing of Invesco QQQ outside of North America and represents a milestone in the expanding market for ETFs in Hong Kong. By trading on HKEX – one of the world’s leading exchanges – investors around the region will have a highly efficient method of accessing the deep liquidity and price transparency of Invesco QQQ, in a convenient time zone.

Invesco QQQ is the most liquid ETF to access the performance of the Nasdaq-100 Index^®, which tracks the 100 largest non-financial companies listed on the Nasdaq. Companies in the Nasdaq-100 Index spend between 600-1,200% more on research and development compared to companies residing in broad-based US large cap equity indexes^[5]. Investors will also be able to invest in their preferred currency, with USD, HKD and RMB counters available. 

“We are honored to bring our flagship ETF – Invesco QQQ – to Hong Kong, offering local investors a valuable opportunity to access the innovative, forward-thinking companies included in the Nasdaq-100 Index,” remarked Andrew Lo, Chief Executive, Asia Pacific at Invesco. “Hong Kong has long been a key hub for Invesco’s APAC business, which makes it the ideal location for Invesco QQQ’s first cross-listing outside of North America. We believe Hong Kong’s unique position in Asia Pacific, as well as its well-established financial infrastructure, will enable us to strategically connect our stakeholders and investors in the region with this important large-cap growth strategy.”

Invesco QQQ has mirrored the evolution of global technology and innovation since its launch in 1999. Of the 22 companies that have been a part of Invesco QQQ since inception, many were in the early stages of development in 1999 and have since scaled up successfully. The average market cap of companies included in Invesco QQQ was US$200 billion in 1999, growing to US$1.39 trillion at the end of 2024^[6]. Many of the constituents of Invesco QQQ include the leading names in global technology, and the index regularly extends to companies beyond the technology sector that capture future growth opportunities.

“Invesco QQQ ETF has a track record of strong performance over its 25-year history, offering investors access to innovative, growing companies with strong fundamentals,” said Brian Hartigan, Global Head of ETFs and Index Investments at Invesco. “Together with Nasdaq, we are pleased to continue to break new ground together through this cross-listing in Hong Kong.”

Invesco QQQ is a unit investment trust designed to track the investment results, before fees and expenses, of the Nasdaq-100 Index. It holds all the stocks included in the Nasdaq-100 Index and trades on the Nasdaq stock exchange under the ticker symbol QQQ.

“We believe this cross-listing will bring immense benefits to Asia Pacific investors, most notably access to local trading lines during market hours and settlement in international currencies. These advantages will further drive the expansion of Hong Kong’s ETF landscape,” Mr. Lo added. “This cross-listing demonstrates our commitment to leveraging our innovative, global investment expertise to investors in Asia Pacific.”

About Invesco

Invesco is an independent investment management firm dedicated to delivering an investment experience that helps people get more out of life. NYSE: IVZ; www.invesco.com.

Important information

All data are sourced from Invesco dated January 31, 2025, unless otherwise stated.

Investment involves risks. Past performance is not indicative of future performance. Investors should read the relevant prospectus for details, including the risk factors and product features. This material has not been reviewed by the Securities and Futures Commission and is issued by Invesco Hong Kong Limited.

Nasdaq®, Nasdaq-100® and Nasdaq-100 Index®; and QQQ® are registered trademarks of Nasdaq, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies or Nasdaq proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

© 2025. Nasdaq, Inc. All Rights Reserved.

Where Andrew Lo and Brian Hartigan have expressed opinions, they are based on current market conditions and are subject to change without notice. These opinions may differ from those of other Invesco investment professionals.

HO CHI MINH CITY, Vietnam, Feb. 26, 2025 /PRNewswire/ — Organized by Global Sources, the Global Sourcing Fair Vietnam 2025 returns for its third edition from April 24 to 26 at the Saigon Exhibition and Convention Center (SECC), Ho Chi Minh City. As a premier B2B trade show, the event will welcome over 10,000 global buyers and feature more than 500 verified manufacturers from Vietnam and Asia across key industries, including Fashion & Accessories, Home & Gifts, and Electronics & Home Appliances.

Vietnam is emerging as a leading sourcing destination, known for cost-effective, high-quality, and export-ready products. Seventy percent of exhibitors are Vietnamese manufacturers, giving buyers direct access to Made-in-Vietnam solutions. The remaining 30% includes suppliers from Mainland China, Hong Kong SAR, Taiwan area, India, Bangladesh, and South Korea, ensuring a diverse and well-rounded supplier base.

With access to over 30,000 export-ready products, buyers can connect with OEM, ODM, and OBM manufacturers, discover the latest innovations, and build lasting partnerships with suppliers offering competitive pricing and flexible production capabilities.

Key Sourcing Categories & Industry Trends

The fair showcases high-demand product categories, including Fashion Apparel, Fashion Accessories & Footwear, Furniture & Home Décor, Household Supplies, Fabric & Textile Supplies, Bags & Luggage, Gifts & Stationery, Packaging, Festival & Occasional Gifts, Art & Craft Supplies, and Home & Housewares.

Exhibitors from Vietnam and Asia offer a diverse of trending, sustainable, and high-demand products, providing buyers with more choices to meet evolving market needs. From eco-friendly home décor and ethically sourced fashion pieces to innovative household essentials, attendees can stay ahead of market trends and gain exclusive access to the latest products that are shaping the global sourcing landscape.

Streamline Your Sourcing Journey with 1-on-1 Business Matching

Beyond product discovery, the show elevates the buyer experience through its exclusive Business Matching Program. This program allows buyers to schedule one-on-one pre-arranged meetings with top suppliers while enjoying exclusive benefits, ensuring a seamless and efficient sourcing experience.

Recognized by leading international brands, the event has welcomed past attendees such as Forcast, El Corte Inglés, Enchanté Accessories, Target, Mars, Walmart Sourcing, Sam’s Club, Li & Fung, Adidas, ACFC, Maison Corporation, Kingfisher and more.

Be a part of Global Sourcing Fair Vietnam 2025 – connect with top suppliers, discover thousands of export-ready products, and gain a competitive edge in global sourcing.

For more information, please visit https://sourcingfairvn.globalsources.com/ or contact us at gsfvietnam@globalsources.com.

GUANGZHOU, China, Feb. 26, 2025 /PRNewswire/ — The American Chamber of Commerce in South China (AmCham South China) today released its 2025 Special Report on the State of Business in South China. The release was attended by over 200 government officials, business executives and members of media including over 40 foreign consulates mostly represented by their consuls general. This publication can be downloaded free of charge from the Chamber’s website at http://www.amcham-southchina.com/amcham/static/publications/specialreport.jsp

The 208-page bilingual 2025 Special Report on the State of the Business in South China, the 21^st such endeavor, provides a comprehensive and quantitative analysis of the business community and valuable insights into the development trends in South China. This year, 316 companies participated in the study in total. This publication is researched and produced independently by AmCham South China and does not represent the opinions of the US or any other government or organization. AmCham South China does not receive any funds from any government in the production of this publication.

According to the 2025 Special Report on the State of Business in South China, 76% of the companies studied plan to reinvest in China in 2025. A sizeable number of the participating companies have budgeted for reinvestment in China in 2025 under US$10 million, accounting for 77% of the total. A notable 6% have allocated over US$250 million for reinvestment plans in the coming year. It is estimated that member companies have set aside a total of US$14.59 billion from profits in China to reinvest over the next three to five years to expand existing operations and capture additional market share, a surge of 33.18% compared to the previous reinvestment figure.

Dr. Harley Seyedin, Chairman and President of AmCham South China, winner of 2017 Oslo Business for Peace Award (along with Elon Musk, Durreen Shahnaz and Murad Al-Katib), which is awarded by an Award Committee consisting of Nobel Laureates in Peace and Economics, said, “Businesses are increasing their commitments in China to secure a stronger foothold in this critical market. The reinvestment surge signals confidence in China’s future, and their hope for US-China increased cooperation.” Dr. Seyedin continued, “Since nearly 75% of American companies in China are primarily focused on importing components from the US to produce goods and services in China for China, they believe that continued reinvestment in China is essential for their long-term success.”

In 2024, China achieved a GDP growth rate of 5% and a total GDP of RMB 134.91 trillion (US$18.80 trillion). This robust economic performance continues to attract global investors, with 39% of the companies studied ranking China as their top investment destination and 58% of foreign companies placing it among their top three global investment priorities. The 2025 Special Report further highlights strong investor confidence, as 73% of the participating companies report a positive or very positive overall return on investment in China in 2024, while 39% enjoy a higher return on investment in China than in other global markets.

Key Takeaways of the 2025 Special Report on the State of Business in South China:

• The proportion of companies that gained over 60% of their global revenue from China has risen by 5 percentage points (pp) to 31%.
• 47% of the companies studied experienced a significant or slight increase in revenue in China. A larger share of American companies (43%, +7pp y-o-y) and manufacturing companies (47%, +17pp y-o-y) experienced revenue growth.
• In 2024, overall profitability declined, with 85% of companies reporting profitability in China, a 3pp decrease compared to the previous two years.
• Concerning the companies that are profitable in China, 45% reported to have met their budget expectations. Among companies yet to make profits in China, 88% expect to reach that milestone within two to five years. Only 8% anticipate it will take more than six years.
• In 2024, 57% of the companies studied remain optimistic about their business prospects in China, a 5pp decrease from the previous year. American companies’ confidence dropped by 14pp, while the manufacturing sector saw the steepest decline, with an 18pp drop in optimism.
• In 2024, 61% of the companies studied reported to have reinvested in China, marking a 5pp decline compared with the previous year. The reinvestment trend remains consistent for American companies, with 57% reporting to have actually reinvested in China, in line with last year’s figures.
• 3% of the companies studied had each budgeted to reinvest US$250 million or more in China in 2024, while this year’s findings reveal that 7% had actually followed through with reinvestments of this magnitude.
• 59% of the companies studied have plans to expand their operations in China over the coming three years.
• Guangzhou has been ranked as the top investment destination in China for eight consecutive years, followed by Shenzhen, Shanghai, and Beijing.
• Fierce local competition remains the greatest challenge faced by the companies studied in South China, followed by rising labor costs and rising operation costs.
• Not a single company indicated a complete withdrawal from the Chinese market. 91% of the companies studied assert that they will not decouple from the Chinese market due to the US-China trade tensions, a 5pp increase from 2023.
• One quarter of the companies studied are bullish about the US-China relations in the coming year, a significant decrease of 19pp compared to previous assessments.

The negative effects of both US and Chinese tariffs on the companies studied have been somewhat alleviated. Many companies have found ways to mitigate the impact through supply chain adjustments, strategic sourcing, or absorbing some of the tariff costs.

Dr. Seydin remarked, “American companies have long recognized the importance of the strong economic relationship between the two countries, and they remain committed to the mutual benefits of innovation, job creation, and cultural exchange that this partnership fosters. It is essential that both governments work together to create a more predictable and supportive trade environment where American businesses can continue to thrive and contribute to the long-term economic growth of both countries.”

Special Report on the State of Business in South China

The Special Report on the State of Business in South China is a quantitative study of the business environment, conducted for consecutive years by AmCham South China. Each year, AmCham’s member and non-member companies participate in AmCham’s State of Business study, results of which will be garnered and edited into a separate publication.

The document can be downloaded free of charge from the chamber’s website at http://www.amcham-southchina.com/amcham/static/publications/specialreport.jsp 

About the American Chamber of Commerce in South China

The American Chamber of Commerce in South China (AmCham South China) is a non-partisan, non-profit organization dedicated to facilitating bilateral trade between the United States and the People’s Republic of China. Accredited in 1995 by the US Chamber of Commerce in Washington DC, AmCham South China represents more than 2,300 corporate and individual members, is governed by a fully-independent Board of Governors elected from its membership, and provides dynamic, on-the-ground support for American and international companies doing business in South China. Over the past decade, AmCham South China has hosted on average each year more than 10,000 business executives and government leaders from around the world at its briefings, seminars, committee meetings and social gatherings. All AmChams in China are independently governed and represent member companies in their respective regions.

• Hyundai Motor and Samsung collaborate to verify Private 5G (P-5G) RedCap technology, enabling fast, seamless communication with lower power consumption and cost
• P-5G RedCap technology to be showcased at MWC25 Barcelona, highlighting advancements in the mobility manufacturing sector
• Hyundai Ulsan Plant and Hyundai Motor Group Metaplant America (HMGMA) pioneers P-5G in mass production, with plans to expand to the new EV-dedicated plant in Ulsan

SEOUL, South Korea and BARCELONA, Spain, Feb. 26, 2025 /PRNewswire/ — Hyundai Motor Company announced today that it has successfully completed a pilot project for Private 5G (P-5G) RedCap (Reduced Capability) technology in partnership with Samsung Electronics Co., Ltd. The company will showcase the technology at MWC25 Barcelona, the world’s largest IT and electronics exhibition, which will be held in Spain from March 3rd to 6th.

As a leader in future mobility, Hyundai Motor advances smart mobility solutions through electrification, software-driven capabilities, and smart manufacturing technologies. To achieve this, the company has collaborated with Samsung, a global leader in network solutions, to become the first in the mobility manufacturing sector to verify P-5G RedCap technology.

“Hyundai Motor was the first Korean company to implement P-5G in mass production,” said Jae Min Lee, Vice President and Head of E-FOREST Center of Hyundai Motor and Kia. “We are also the industry’s first to verify P-5G RedCap technology, reinforcing our global leadership in smart manufacturing solutions. We will continue to accelerate its commercialization.”

Simon Lee, Vice President and Head of B2B•B2G Business Development, Networks Business at Samsung Electronics said: “The recent collaboration with Hyundai Motor represents how the two leaders in their respective industries can creatively drive business innovation and unlock new real use cases by merging best-in-class expertise. Samsung’s RedCap-powered private 5G network solutions will open up more possibilities for enterprises, manufacturers, and public institutions, serving as a gateway to driving more efficient 5G networks.”

Since January 2025, Hyundai Motor has completed testing of Samsung’s P-5G solutions including radio, core, and management systems with its in-house vehicle inspection equipment at Samsung’s Suwon campus. They developed a custom vehicle inspection device to verify the network’s operational capabilities.

P-5G is a dedicated system installed onsite using a specific frequency band, ensuring no external interference and seamless data transmission — essential for smart manufacturing with centralized control of industrial robots and devices. It can be tailored for optimized environments and stable communication, though challenges like complex design and high power consumption remain.

The collaboration successfully verified the P-5G RedCap technology, which offers simplified device configurations, compact infrastructure, and reduced bandwidth usage. This results in lower power consumption, cost efficiency, and improved performance over traditional Wi-Fi in speed, data processing, connection stability, and low latency.

Previously limited to high-performance equipment, RedCap technology enables high-speed wireless communication for vehicle inspection equipment, small tools, cameras and tablets. Hyundai Motor integrated RedCap enabled Qualcomm’s Snapdragon® X35 5G Modem-RF System chipsets into its Diagnostic Scan (D Scan) system for efficient vehicle inspection data transmission via Samsung’s 5G network.

Samsung’s P-5G solution, with support for optimized RedCap software, reduces power consumption and more than doubles uplink capacity for real-time IoT data transmission, featuring an integrated management system for automation.

Looking ahead, Hyundai Motor plans to integrate P-5G into its new EV-dedicated plant in Ulsan, opening in 2026. This latest verification of RedCap technology is set to enhance the company’s smart manufacturing ecosystem, with further expansions planned for key plants.

About Hyundai Motor Company

More information about Hyundai Motor and its products can be found at: https://www.hyundai.com/worldwide/en/ or Newsroom: Media Hub by Hyundai

BEIJING, Feb. 26, 2025 /PRNewswire/ — On February 22, 2025, the Forbes China Emerging Innovators and Entrepreneurs Forum and Awards Ceremony was held at the Shangri La Hotel in Hangzhou. This grand event of innovation and entrepreneurship brought together entrepreneurs, investors, and industry experts from all walks of life to explore global innovation trends. In the highly anticipated Award Ceremony, Kelly Xu, Founder and CEO of E-Health Now, stood out in the fierce competition with her outstanding achievements and innovative spirit, and won the prize of the “2024 Forbes China Emerging Innovators and Entrepreneurs” in the area of “Life and Health”.

Forbes China, as an internationally renowned media brand with innovation as its core, has long been deeply involved in innovation. The newly launched Award of “Innovators & Entrepreneurs” aims to discover outstanding companies and talents with high growth potential and investment value worldwide, and further promote global innovation practice. The selection process is rigorous and scientific, and through in-depth analysis and layer by layer screening of multi-dimensional criteria such as candidates’ business performance, capital market performance, industry influence, and innovation capability, each person on the list is a leader in the industry. Kelly Xu truly deserved the award.

Since founding E-Health Now in 2017, Kelly Xu has demonstrated extraordinary strategic vision and leadership. Under her leadership, E-Health Now stood out in the fiercely competitive market and quickly rose to become a benchmark enterprise in the industry. The company relies on nearly 10,000 high-quality domestic and international medical institutes and other scarce medical resources that have signed official contracts for cooperation, as well as a smart medical and health management service system that covers the entire value chain of life and health service process. Through more than 100 carefully designed medical and health online and offline products and services, the company can tailor comprehensive and personalized health solutions for insurance, banking, corporates, and individual customers with an innovative B2B2C model. At present, it has established deep strategic partnerships with over 210 insurance companies, banks, and corporate clients, completed a stable and extensive industry ecosystem cooperation network, served over 35 million end users, and thus won market recognition and user trust with its excellent services & user experience.

Kelly Xu also strategically led E-Health Now to lay out and invest in the field of artificial intelligence in 2021 with an outstanding vision. Currently, the company has successfully developed and launched 5 AI medical intelligent tools, which combined with its medical services have helped to significantly improve the efficiency and quality of medical services, reduce costs, and greatly optimize user experience, setting a new example of intelligent healthcare services in the industry. Under her leadership, E-Health Now has achieved 100% CAGR revenue growth in the past years, such extraordinary development also gained recognition from the capital market, and it has obtained investment from a series of top venture capitals such as Ventech China, GSR, Suzhou City Wujiang Venture Capital, Borchid Capital, Tongji Fund, etc.

Looking forward, Kelly Xu stated that E-Health Now would actively explore overseas markets while continuously strengthening and developing its domestic China business. The Company plans to empower overseas hospitals and insurance companies with advanced AI technology and medical solutions, and promote the cross-border flow of high-quality medical and health services. It plans to start with the Southeast Asian market, and will bring the most advanced medical and health solutions to countries such as Singapore, Thailand, Indonesia, Vietnam, and is already in discussion with potential local partners.

Kelly Xu’s inclusion in the “2024 Forbes China Emerging Innovators and Entrepreneurs” list is not only a significant affirmation of her personal career, but also a high recognition of E-Health Now’s innovative business model. It can be highly anticipated that under the leadership of Kelly Xu, E-Health Now will continue to lead on the path of innovation and entrepreneurship, create even more brilliant achievements, and inject new vitality into promoting industry development and supporting economic growth.

Company Name: E-Health Now Health Technology (Beijing) Co., Ltd
Contact Person: Ms. Luo
Email: marketing@ehealthnow.cn
Website: www.huameihaolian.com 
Telephone: +8615801167074
City: Beijing, China

• People who have had shingles are at a 59% higher risk for heart attack and at a 35% higher risk for stroke compared to those who have not had shingles.
• Adults aged 50 years or over are at high risk for shingles due to age-related decline in immunity and the risk further increases amongst those with underlying chronic health conditions such as chronic obstructive pulmonary disease (COPD), cardiovascular disease, and diabetes.
• If people with diabetes contract shingles, they are at least three times more likely to be hospitalised due to shingles compared to those without diabetes.

SINGAPORE, Feb. 26, 2025 /PRNewswire/ — A study has reported that people who have had shingles, also known as herpes zoster, are at a significantly higher risk of heart attack (+59%) and stroke (+35%) compared to those who have not had shingles.^[1] In another study, it has been reported that people with diabetes are at least three times more likely to be hospitalised due to shingles compared to those without diabetes.^[2]

Shingles is a viral infection caused by the reactivation of the varicella-zoster virus — the same virus that causes chickenpox.^[3] With age-related decline in immunity, people aged 50 years or over are at a higher risk for contracting shingles compared to those who are younger.^[4],[5]

The risk for shingles further increases amongst people with underlying chronic health conditions, such as chronic obstructive pulmonary disease (COPD), cardiovascular diseases, and diabetes.^[6]

In Singapore, around nine out of ten adults aged 50 years or over have had chickenpox^[7] and 85% of the country’s older population live with at least one chronic health condition, while 45% have been diagnosed with three or more.^[8]

The five most reported chronic health conditions amongst older adults in Singapore were: high blood pressure or hypertension; high blood cholesterol or lipids; joint pain, arthritis, or nerve pain; high blood sugar or diabetes; and renal/kidney or urinary tract ailments. ^[9]

Dr. Sue-Anne Ee Shiow Toh, Endocrinologist and Co-Founder and Chief Executive Officer at NOVI Health, shared with GSK that from a clinical perspective, the impact of shingles on people with chronic health conditions or comorbidities can be severe.

‘Ageing patients with comorbidities are more susceptible to infections, and when shingles occurs, it can lead to prolonged healing times, increased nerve pain, and even heightened cardiovascular risks,’ shared Dr. Toh.

People with diabetes, for example, are at a 30% higher risk of getting shingles compared to those who do not have diabetes.^[10] If they do contract shingles, they are at least three times more likely to be hospitalised due to shingles compared to those without diabetes.^[11]

Mr. Satyaprakash Tiwari, Executive Director, Diabetes Singapore, shared with GSK: ‘Diabetes is a chronic condition that already presents many health challenges. The additional risk of shingles and its complications is something that many people with diabetes may not be aware of.’

During this year’s Shingles Awareness Week, GSK has partnered with Diabetes Singapore to raise awareness about the risks of shingles for people with diabetes and launched a campaign to share experiences of people who have had shingles. One such experience is that of Mr. Lionel L., a businessman from Singapore, who contracted the disease at the age of 56.

Raakhi Sippy, General Manager of GSK Singapore, commented: ‘Many people are unaware of the risks associated with shingles, such as increased risk of heart attack, stroke, and hospitalisation. Raising awareness, especially amongst Singaporeans aged 50 years or over, is a key step towards protecting them from shingles and related complications.’

‘Given these risks, it is important that individuals over 50, particularly those with comorbidities, are informed about the available preventive measures against shingles,’ Dr. Toh added.

For more information on shingles and the Shingles Awareness Week campaign, visit https://www.stopshingles.com.

About Shingles Awareness Week 

Shingles Awareness Week (23 February – 1 March 2025) is an annual global awareness week dedicated to improving public knowledge about the risks and severity of shingles. In collaboration with the International Federation on Ageing (IFA), GSK has set up the Shingles Awareness Week to encourage informed conversations between adults, particularly those aged 50 years or over, and their healthcare professionals about shingles.

About GSK Singapore

GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.

With the aim to positively impact the health of 2.5 billion people at the end of the decade, GSK prioritises innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is the company’s R&D focus on the science of the immune system, human genetics and advanced technologies, and world-leading capabilities in vaccines and medicines development.

Singapore is the hub for GSK’s Global General Medicines (GM) and the Greater China and Intercontinental (GCI) and Emerging Markets (EM) regions. It houses three manufacturing sites (Jurong, Quality Road, Tuas), comprising two for medicines and one for vaccines. GSK’s business in Singapore is spread across four sites – the three manufacturing sites and its corporate and commercial office (GSK Asia House).    

For more information on GSK please go to https://www.gsk.com/en-gb/      

IPOH, Malaysia, Feb. 26, 2025 /PRNewswire/ — Zuliz, a leading Chinese elderly footwear brand, has taken a significant step in its global expansion with the opening of its first store in Malaysia. This move underscores the brand’s commitment to strengthening its international presence and advancing its globalization strategy. 

The launch follows Zuliz’s successful showcase at the Malaysia International Trade Expo in August 2024, where its innovative elderly footwear range attracted widespread attention. The event led to a strategic partnership with a local distributor, facilitating Zuliz’s entry into the Southeast Asian market. The new store not only cements the brand’s regional presence but also highlights its growing influence in the global elderly care sector. 

Global Ageing: A Catalyst for Growth

Zuliz’s expansion aligns with significant demographic shifts. By 2024, the global population aged 65 and above reached 783 million, representing 9.1% of the world’s population. This ageing trend has created both challenges and opportunities, particularly in the elderly care market, where demand for high-quality, age-specific products is rising rapidly. 

Invitation to Join Zuliz’s Global Partner Programme 

To capitalize on these trends, Zuliz is inviting businesses worldwide to join its Global Partner Programme. The initiative offers comprehensive support in branding, product development, and operational strategies, providing a unique opportunity to collaborate with a market leader in elderly footwear. 

The programme is more than a commercial venture; it is a gateway to the burgeoning silver economy, a sector poised for exponential growth as ageing populations reshape global markets. By partnering with Zuliz, businesses can unlock significant commercial value while contributing to improving the quality of life for elderly individuals worldwide. 

As Zuliz continues to expand its international footprint, the brand remains focused on delivering innovative, high-quality solutions tailored to the needs of an ageing world. The Malaysia store opening marks a pivotal chapter in Zuliz’s journey toward becoming a global leader in elderly care products.